Herein, we uncovered a new NEAT1/miR-139-5p axis promoting HSCs activation and driving liver fibrosis development by modulating the β-catenin/SOX9/TGF-β1 signaling, providing potential targets for the early diagnosis and treatment of liver fibrosis. The gene discussed is SOX9; the disease is Hepatic fibrosis.